$23M sweet spot round size
Most of their 25 investments are in rounds between $14M and $39M
2011
Click Therapeutics, Inc. raised $52M on October 22, 2021
Investors: Sanofi Ventures, Revelation Partners, K2 HealthVentures, Accelmed, Hikma Ventures, Health Catalyst Capital Management LLC and H.I.G. BioVentures
Arvelle Therapeutics raised $43M on May 27, 2020
Investors: KB Investment, Andera Partners, -, EQT Life Sciences, BPV Capital Management - Back Porch Vista, F-Prime Capital Partners and H.I.G. BioVentures
Clarify Medical raised $18M on October 23, 2019
Investors: SV Life Sciences, 7wire Ventures, Bluestem Capital Co and H.I.G. BioVentures
Exagen Diagnostics, Inc. raised $23M on July 16, 2019
Investors: Sun Mountain Capital, Tullis Health Investors and H.I.G. BioVentures
Intact Vascular raised $25M on May 30, 2019
Investors: Vensana Capital and H.I.G. BioVentures
Arvelle Therapeutics raised $179M on February 18, 2019
Investors: Andera Partners, BPV Capital Management - Back Porch Vista, EQT Life Sciences, NovaQuest Capital Management and H.I.G. BioVentures
Iconic Therapeutics, Inc. raised $4.1M on June 15, 2018
Investors: Lundbeckfonden / Lundbeck Foundation, MPM Capital, Elm Street Ventures, JLABS, HBM Partners AG, Osage University Partners (OUP) and H.I.G. BioVentures
Neurana Pharmaceuticals raised $60M on May 8, 2018
Investors: New Leaf Venture Partners, Sofinnova Ventures, Russia technology fund, Longitude Capital and H.I.G. BioVentures
Intact Vascular raised $20M on April 16, 2018
Investors: H.I.G. BioVentures
On Target Laboratories raised $4M on March 14, 2018
Investors: 3B Future Health Fund, Elevate Ventures and H.I.G. BioVentures